by admin | Sep 10, 2019 | Licensing, Partnerships
Grünenthal, a global leader in pain management, and Mesoblast Limited, a world leader in allogeneic cellular medicines for inflammatory diseases, announced that they have entered into a strategic partnership to develop and commercialise MPC-06-ID, a Phase III...
by admin | Sep 9, 2019 | Clinical Trials
AXON Neuroscience, an industry leading, clinical stage biotech at the forefront of treatment and prevention of Alzheimer’s disease, has announced the results of the Phase II trial for AADvac1, its first-in-class vaccine to slow down the progression of...
by admin | Sep 8, 2019 | Clinical Trials
Orion Biotechnology announced that the Polish National Regulatory Agency and Local Ethics Committee have given approval for the OB-002H-101 Phase 1 safety and acceptability study of OB-002H gel to start screening and enrollment. The OB-002H gel is a topical...
